← Back to Screener
OKYO Pharma Limited Ordinary Shares (OKYO)
Price$1.66
Favorite Metrics
Price vs S&P 500 (26W)-23.79%
Price vs S&P 500 (4W)-3.76%
Market Capitalization$110.53M
All Metrics
Book Value / Share (Quarterly)$9.19
P/TBV (Annual)19.88x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.11
Price vs S&P 500 (YTD)-23.95%
EPS (TTM)$-0.15
10-Day Avg Trading Volume0.11M
EPS Excl Extra (TTM)$-0.15
EPS (Annual)$-0.16
ROI (Annual)-177.68%
Cash / Share (Quarterly)$0.15
ROA (Last FY)-127.98%
EBITD / Share (TTM)$-0.20
Cash Flow / Share (Annual)$-0.07
P/B Ratio26.97x
P/B Ratio (Quarterly)38.74x
Net Income / Employee (Annual)$-2
Net Interest Coverage (TTM)-8.22x
ROA (TTM)-110.88%
EPS Incl Extra (Annual)$-0.16
Current Ratio (Annual)0.40x
Quick Ratio (Quarterly)0.53x
3-Month Avg Trading Volume0.22M
52-Week Price Return46.92%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$-1.56
52-Week High$3.35
EPS Excl Extra (Annual)$-0.16
26-Week Price Return-15.05%
Quick Ratio (Annual)0.37x
13-Week Price Return-41.34%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.58x
Enterprise Value$76.296
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.06
3-Month Return Std Dev80.43%
Net Income / Employee (TTM)$-2
ROE (Last FY)-177.68%
Net Interest Coverage (Annual)-30.61x
EPS Basic Excl Extra (Annual)$-0.16
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.15
Receivables Turnover (Annual)0.00x
ROI (TTM)-133.11%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$11.63
Price vs S&P 500 (52W)11.82%
Year-to-Date Return-19.81%
5-Day Price Return8.50%
EPS Normalized (Annual)$-0.16
ROA (5Y Avg)-329.24%
Month-to-Date Return3.11%
Cash Flow / Share (TTM)$-38.88
EBITD / Share (Annual)$-0.24
EPS Basic Excl Extra (TTM)$-0.15
P/B Ratio (Annual)38.74x
Book Value / Share (Annual)$9.19
Price vs S&P 500 (13W)-44.21%
Beta0.08x
Revenue / Share (TTM)$0.00
ROE (TTM)-134.46%
52-Week Low$1.10
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.11
4.11
4.10
4.10
Industry Peers — Biological Products(89)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
OKYOOKYO Pharma Limited Ordinary Shares | — | — | — | — | $1.66 |
AMGNAmgen Inc | 5.21x | 9.95% | 73.30% | 2.93% | $355.30 |
GILDGilead Sciences Inc | 5.80x | 2.40% | 78.83% | 133.64% | $137.64 |
ARGXargenx SE American Depositary Shares | 12.46x | 89.56% | 150.91% | — | $849.04 |
BNTXBioNTech SE American Depositary Share | 8.99x | -11.81% | 84.21% | — | $102.92 |
BIIBBiogen Inc. Common Stock | 2.63x | 2.22% | 75.69% | -18.77% | $177.35 |
MRNAModerna, Inc. Common Stock | 10.91x | -39.93% | 70.32% | — | $53.72 |
NBIXNeurocrine Biosciences Inc | 4.68x | 21.45% | 98.18% | 2.31% | $133.25 |
EXELExelixis Inc | 5.02x | 6.85% | 96.39% | 31.10% | $44.89 |
TECHBio-Techne Corp. | 7.62x | 1.64% | 66.60% | -20.58% | $59.23 |
HALOHalozyme Therapeutics, Inc. | 5.88x | 37.55% | 83.62% | 22.89% | $69.29 |
About
OKYO Pharma is a biopharmaceutical company developing innovative therapies for inflammatory eye diseases and chronic pain conditions. The company's pipeline targets key indications including Dry Eye Disease, Non-infectious Anterior Uveitis, Allergic Conjunctivitis, and chronic/ocular pain. It addresses underserved patient populations with significant unmet medical needs in ophthalmology and pain management.